Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | NPC1 | O15118 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.43 |
| ▸ | RELA | Q04206 | 1/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | ACR | P10323 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.40 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.39 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL223023 | 1.00 | MEN1 (0.71) | MEN1KMT2ANPC1LMNASMN1; SMN2 | |
| SCHEMBL222127 | 0.97 | MEN1 (0.67) | MEN1KMT2ANPC1LMNASMN1; SMN2 | |
| SCHEMBL12768363 | 0.95 | KMT2A (0.78) | MEN1KMT2ANPC1LMNASMN1; SMN2 | |
| SCHEMBL1531938 | 0.95 | KMT2A (0.78) | MEN1KMT2ANPC1LMNASMN1; SMN2 | |
| SCHEMBL1531771 | 0.92 | MEN1 (0.73) | MEN1KMT2ANPC1LMNASMN1; SMN2 | |
| SCHEMBL29551049 | 0.91 | KMT2A (0.75) | MEN1KMT2ANPC1LMNASMN1; SMN2 | |
| SCHEMBL22089857 | 0.91 | MEN1 (0.87) | MEN1KMT2ANPC1LMNASMN1; SMN2 | |
| SCHEMBL22102520 | 0.91 | KMT2A (0.71) | MEN1KMT2ANPC1LMNASMN1; SMN2 | |
| SCHEMBL221305 | 0.90 | KMT2A (0.70) | MEN1KMT2ANPC1LMNASMN1; SMN2 | |
| SCHEMBL13572552 | 0.90 | KMT2A (0.70) | MEN1KMT2ANPC1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106701106-B | Alignment mechanism for optical dyes | 光学转变公司 | 2022-03-29 | — | — | CN | disclosed |
| EP-2358845-B1 | ALIGNMENT FACILITIES FOR OPTICAL DYES | TRANSITIONS OPTICAL INC (US) | 2014-11-12 | — | — | EP | disclosed |
| US-8828507-B2 | Alignment facilities for optical dyes | TRANSITIONS OPTICAL, INC. (US) | 2014-09-09 | — | — | US | disclosed |
| US-8613868-B2 | Mesogenic stabilizers | TRANSITIONS OPTICAL, INC (US) | 2013-12-24 | — | — | US | disclosed |
| WO-2013022610-A1 | MESOGENIC STABILIZERS | TRANSITIONS OPTICAL, INC. (US) | 2013-02-14 | — | — | WO | disclosed |
| US-20120021144-A1 | MESOGENIC STABILIZERS | TRANSITIONS OPTICAL, INC. (US) | 2012-01-26 | — | — | US | disclosed |
| EP-2358845-A1 | ALIGNMENT FACILITIES FOR OPTICAL DYES | TRANSITIONS OPTICAL, INC. (US) | 2011-08-24 | — | — | EP | disclosed |
| US-8003005-B2 | Alignment facilities for optical dyes | TRANSITIONS OPTICAL, INC. (US) | 2011-08-23 | — | — | US | disclosed |
| US-20110128457-A1 | ALIGNMENT FACILITIES FOR OPTICAL DYES | TRANSITIONS OPTICAL, INC. (US) | 2011-06-02 | — | — | US | disclosed |
| WO-2010065406-A1 | ALIGNMENT FACILITIES FOR OPTICAL DYES | TRANSITIONS OPTICAL, INC. (US) | 2010-06-10 | — | — | WO | disclosed |
| US-20090146104-A1 | ALIGNMENT FACILITIES FOR OPTICAL DYES | TRANSITIONS OPTICAL, INC. (US) | 2009-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120021144-A1 | MESOGENIC STABILIZERS | C1S, C5, CCNL2 | MEN1 9/4885KMT2A 1363/4885NPC1 2614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.